Richard Daniell

Insider Reports History

Entity
Individual
Location
5 Basel Street, Po Box 3190, Petach Tikva, Israel
Signature
/s/ Dov Bergwerk as attorney-in-fact for Richard Daniell
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Richard Daniell:

Stock Role Class Num Shares Value Price $ Report Date Ownership
TEVA PHARMACEUTICAL INDUSTRIES LTD Exec. VP, European Commercial Ordinary Shares 0 $0 $17.30 Aug 12, 2024 Direct
TEVA PHARMACEUTICAL INDUSTRIES LTD Exec. VP, European Commercial Restricted Share Units 0 Mar 5, 2024 Direct

Insider Reports Filed by Richard Daniell

Symbol Company Period Transactions Value $ Form Type Date Filed Role
TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD Aug 12, 2024 1 -$1.71M 4 Aug 13, 2024 Exec. VP, European Commercial
TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD Mar 5, 2024 6 -$657K 4 Mar 7, 2024 Exec. VP, European Commercial
TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD Mar 3, 2024 7 -$1.28M 4 Mar 5, 2024 Exec. VP, European Commercial
TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD Feb 28, 2024 3 -$270K 4 Mar 1, 2024 Exec. VP, European Commercial
TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD Jan 30, 2024 1 $0 4 Feb 1, 2024 Exec. VP, European Commercial
TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD Mar 6, 2023 2 -$688K 4 Mar 8, 2023 Exec. VP, European Commercial
TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD Mar 3, 2023 7 $0 4 Mar 7, 2023 Exec. VP, European Commercial
TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD Feb 28, 2023 6 -$438K 4 Mar 2, 2023 Exec. VP, European Commercial
TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD Feb 7, 2023 1 $0 4 Feb 9, 2023 Exec. VP, European Commercial
TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD Mar 4, 2022 10 -$438K 4 Mar 8, 2022 Exec. VP, European Commercial
TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD Feb 28, 2022 3 -$168K 4 Mar 2, 2022 Exec. VP, European Commercial
TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD Feb 8, 2022 4 -$119K 4 Feb 10, 2022 Exec. VP, European Commercial